We've just seen a total of 700k new cases in two separate days in two different countries. If 10% of the average total become hospitalized and hypoxic, that's 35k patients per day, or 12.7M patients annually.
The vast majority of those cases will never see a hospital and will either result in death or full recovery before HGEN could produce a few hundred vials. Also, foreign countries don't pay anywhere near what the U.S. pays for drugs and no third world country would ever spend $10k for a dose... Try at most a few hundred dollars.
So, is it unrealistic to think that Humanigen could be looking at stockpile orders totalling 10M vials?
10 million vials?! Management noted it will take 12 months to get production to an annual production rate of 100K units. Clearly, you don't understand what that means.